Uterine scarring breakthrough? 5,000-Woman study tests new surgery and stent
NCT ID NCT07421908
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This large study of 5,000 women with intrauterine adhesions (scarring inside the womb) aims to improve diagnosis and treatment. Researchers will test a new approach that combines 3D ultrasound, a special 'cold knife' surgery, and a silicone uterine stent to prevent scarring from returning. The goal is to see if this new care model helps more women achieve pregnancy within two years after treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cold knife plowing surgery and uterine cavity stent
- What this could lead to
- If successful, this could lead to a standardized, more effective treatment approach for intrauterine adhesions, potentially improving pregnancy rates for affected women.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may take years and might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 5,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Mar 2035
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with intrauterine adhesions diagnosed and treated in our hospital and the sub-central units of this project: aged 18-45 years old; The collection began after the ethical review was passed. A total of 5,000 cases were collected, and 2,000 cases were collected in this center. Exclusion Criteria: * Abnormal ovarian function, male infertility, inability to cooperate with diagnosis and treatment and follow-up visits
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intrauterine adhesion are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.